Group - Bayer wins another glyphosate case in the USA after a dry spell
After a series of defeats, Bayer has won a glyphosate lawsuit in the USA. The decision by a jury in San Benito County in the state of California confirms that the weedkiller glyphosate "is not responsible for the plaintiff's illness", as Bayer announced at the weekend. "We have thus won 10 of the last 15 lawsuits and are encouraged in our strategy of pursuing lawsuits in court."
The DAX-listed pharmaceutical and agrochemical company has recently suffered several setbacks, not only in court, but also in the development of an important drug candidate.
Just last week, a US jury in the state of Washington ordered the Leverkusen-based company to pay damages totaling 857 million US dollars (785 million euros) in a legal dispute over the alleged health effects of PCBs, a chemical that has been banned for decades. This is to be paid to former pupils and parents of a school in the Seattle area. As in other cases, Bayer intends to appeal against the judgment.
The PCB and glyphosate cases are a legacy of the US agrochemical company Monsanto, which was acquired in 2018 for over 60 billion dollars. The settlement of the glyphosate disputes in particular has already cost billions. There is a debate about whether the weedkiller is carcinogenic to humans. Bayer rejects the suspicion.
Read also:
- Why there is still no EU funding for green Saar steel
- 3 billion Saar Fund is unconstitutional
- Lack of snow also opens up new opportunities for winter tourism
- Abrupt end to e-car subsidies
- Despite facing several challenges, including recent court losses and development setbacks for a key drug, Bayer's chemistry division in Germany remains optimistic, citing their recent victory in a glyphosate lawsuit in the United States as a testament to their legal strategy.
- The jury in California's San Benito County ruled that glyphosate, a controversial weedkiller, is not responsible for a plaintiff's illness, a decision that Bayer celebrated as a significant win after a 'thirsty stretch' of court losses.
- The chemical giant, Bayer, has faced numerous lawsuits related to glyphosate and its potential health effects, with mounting legal costs and global controversy.
- As the pharmaceutical and agrochemical giant continues to grapple with legal disputes, Bayer, based in Leverkusen, Germany, has also faced criticism over PCBs, a discontinued chemical linked to health issues.
- In a separate case in Washington State, a jury ordered Bayer to pay damages totaling 857 million US dollars for alleged PCB health effects, marking another financial blow in what has been a costly period for the company.
- Amidst escalating legal costs and ongoing debates around the safety of chemical products like glyphosate and PCBs, US-based organizations have begun questioning the long-term health implications of chemical processes in the pharma and agriculture industries.
Source: www.stern.de
